BACKGROUND Variations in the methylene tetrahydrofolate reductase(MTHFR)gene have been reported as risk factors for numerous conditions,including cardiovascular disease,thrombophilia,stroke,hypertension and pregnancy-...BACKGROUND Variations in the methylene tetrahydrofolate reductase(MTHFR)gene have been reported as risk factors for numerous conditions,including cardiovascular disease,thrombophilia,stroke,hypertension and pregnancy-related complications.Moreover,it was reported there is an association between breast cancer and mutations in MTHFR-C677T.However,whether there is an association between MTHFR gene polymorphism and granulomatous lobular mastitis or not has been rarely investigated.AIM To analyze the association between MTHFR gene polymorphism and granulomatous lobular mastitis.METHODS Fifty-one patients with granulomatous lobular mastitis admitted to The First Hospital of Kunming were selected as study samples.Their hospitalization time ranged from February 2018 to February 2019.The 51 patients were included in the experimental group,and another 51 women who underwent physical examination at The First Hospital of Kunming in the same period were included in the control group.Deoxyribonucleic acid and MTFR genetic polymorphism testing were performed in each group.The association between MTHFR gene polymorphism and granulomatous lobular mastitis was observed.RESULTS There were significant differences in genotype frequency and allele frequency of C/C and C/T between the experimental group and the control group(all P<0.05).However,there was no significant difference in frequency of T/T genotype between the two groups(P>0.05).In addition,there was no significant difference in genotype frequency and allele frequency of A/A,A/C and C/C between the two groups(P>0.05).CONCLUSION MTHFR gene C677T locus polymorphism is closely related to granulomatous lobular mastitis.展开更多
Objective To review the association of methylene tetrahydrofolate reductase (MTHFR) C677T mutant with coronary artery disease, as well as to highlight the results of some of these studies and to emphasize the need to ...Objective To review the association of methylene tetrahydrofolate reductase (MTHFR) C677T mutant with coronary artery disease, as well as to highlight the results of some of these studies and to emphasize the need to focus on the genetic architecture of CAD. Data SourcesData used in this article is mainly from relevant articles obtained through Pubmed, OVID and Google Scholar published from 1980 to 2008. Major studies and trials in this period were taken into account to draw accurate conclusion on the relation of those mutations in MTHFR with homocysteinemia and CAD. ResultOur analysis shows that hyperhomocysteinemia, a risk factor for occlusive arterial diseases, can be caused by disruptions of homocysteine metabolism catalyzed by MFTHR. A common alanine to valine mutation in MTHFR may contribute to mild heperhomocysteinemia in CAD. Individuals with the homozygous mutant genotype had higher plasma homocysteine, particularly when plasma folate was below the median value. ConclusionThis MTHFR mutant in the setting of insufficient folate may be a risk factor of CAD and can be regarded as a model of genetic-environmental interaction in the development of CAD.展开更多
目的分析亚甲基四氢叶酸还原酶(MTHFR)基因多态性对脑梗死患者阿替普酶静脉溶栓后出血性转化(HT)的影响。方法回顾性分析2020年7月—2023年7月在安徽医科大学附属阜阳人民医院接受治疗的120例脑梗死患者的临床资料。依据治疗后24~72 h H...目的分析亚甲基四氢叶酸还原酶(MTHFR)基因多态性对脑梗死患者阿替普酶静脉溶栓后出血性转化(HT)的影响。方法回顾性分析2020年7月—2023年7月在安徽医科大学附属阜阳人民医院接受治疗的120例脑梗死患者的临床资料。依据治疗后24~72 h HT发生情况分为HT组(15例)、无HT组(105例)。比较两组基线资料、MTHFR基因多态性、纤维蛋白原(Fib)、同型半胱氨酸(Hcy)。采用多因素一般Logistic回归模型分析脑梗死患者阿替普酶静脉溶栓后HT发生的危险因素。绘制受试者工作特征(ROC)曲线,分析入院时美国国立卫生院卒中量表(NIHSS)评分、Hcy预测脑梗死患者阿替普酶静脉溶栓后HT发生的价值。结果HT组心房颤动发生率、MTHFR基因型677CT占比、入院时NIHSS评分、Hcy水平均高于无HT组(P<0.05)。多因素一般Logistic回归分析结果显示:心房颤动史[OR=1.478(95%CI:1.126,1.940)]、入院时NIHSS评分升高[OR=1.656(95%CI:1.125,2.438)]、MTHFR基因型为677CT[OR=1.871/2.362(95%CI:1.052,3.328/1.081,4.652)]、Hcy水平升高[OR=2.149(95%CI:1.108,4.168)]均为脑梗死患者阿替普酶静脉溶栓后HT发生的危险因素(P<0.05)。ROC曲线分析结果显示,入院时NIHSS评分、Hcy均可预测脑梗死患者阿替普酶静脉溶栓后HT发生,其敏感性分别为80.0%(95%CI:0.765,0.883)、73.3%(95%CI:0.717,0.834),特异性分别为74.3%(95%CI:0.659,0.817)、74.3%(95%CI:0.824,0.931)。677CT型患者Hcy水平高于677CC、677TT型患者(P<0.05)。结论心房颤动、MTHFR基因型、入院时NIHSS评分、Hcy均为影响脑梗死患者阿替普酶静脉溶栓后HT发生的重要因素,临床应结合以上指标对高危患者进行重点筛查,尽早采取干预措施。展开更多
目的探讨亚甲基四氢叶酸还原酶(MTHFR)基因多态性及纤维蛋白原(Fib)、纤溶酶原激活抑制物-1(PAI-1)与脑梗死患者下肢深静脉血栓(LDVT)的相关性。方法回顾性分析2020年1月~2022年12月在张家口市第一医院接受治疗的脑梗死患者100例。依据...目的探讨亚甲基四氢叶酸还原酶(MTHFR)基因多态性及纤维蛋白原(Fib)、纤溶酶原激活抑制物-1(PAI-1)与脑梗死患者下肢深静脉血栓(LDVT)的相关性。方法回顾性分析2020年1月~2022年12月在张家口市第一医院接受治疗的脑梗死患者100例。依据入院14 d后超声检查结果分为LDVT组(n=27)与无LDVT组(n=73)。比较两组基线资料信息、MTHFR基因多态性以及实验室相关指标,通过ROC分析入院时美国国立卫生研究所脑卒中量表(NIHSS)评分、Fib、PAI-1预测脑梗死患者LDVT的价值。采用多因素logistic回归分析脑梗死患者LDVT的危险因素。结果100例脑梗死患者行超声检测,发现27例(27.00%)发生LDVT,其中股静脉血栓8例(29.63%),胫前静脉血栓6例(22.22%),胫后静脉血栓4例(14.81%),腘静脉血栓4例(14.81%),腓肠肌肌间静脉血栓5例(18.52%);73例(73.00%)脑梗死患者无LDVT。LDVT组房颤、MTHFR基因多态性为CT、TT人数占比以及入院时NIHSS评分、Fib、PAI-1水平高于无LDVT组,差异有统计学意义(P<0.05);经ROC分析证实入院时NIHSS评分、Fib、PAI-1均可预测脑梗死患者LDVT,曲线下面积分别为0.795、0.763、0.801(P<0.05);多因素logistic回归分析证实,房颤、入院时NIHSS评分≥14.810分、MTHFR基因多态性为CC和CT、Fib≥3.800 g L以及PAI-1≥41.005 ng L是脑梗死患者LDVT的危险因素(P<0.05)。结论MTHFR基因多态性及Fib,PAI-1与脑梗死患者LDVT的发生密切相关,房颤、入院时NIHSS评分≥14.810分、MTHFR基因多态性为CC和CT、Fib≥3.800 g L以及PAI-1≥41.005 ng L是脑梗死患者LDVT的危险因素,临床应对符合以上因素的患者进行重点筛查,尽早采取干预措施,改善患者预后。展开更多
基金Supported by the Xishan District Science and Technology Plan Project of Kunming.
文摘BACKGROUND Variations in the methylene tetrahydrofolate reductase(MTHFR)gene have been reported as risk factors for numerous conditions,including cardiovascular disease,thrombophilia,stroke,hypertension and pregnancy-related complications.Moreover,it was reported there is an association between breast cancer and mutations in MTHFR-C677T.However,whether there is an association between MTHFR gene polymorphism and granulomatous lobular mastitis or not has been rarely investigated.AIM To analyze the association between MTHFR gene polymorphism and granulomatous lobular mastitis.METHODS Fifty-one patients with granulomatous lobular mastitis admitted to The First Hospital of Kunming were selected as study samples.Their hospitalization time ranged from February 2018 to February 2019.The 51 patients were included in the experimental group,and another 51 women who underwent physical examination at The First Hospital of Kunming in the same period were included in the control group.Deoxyribonucleic acid and MTFR genetic polymorphism testing were performed in each group.The association between MTHFR gene polymorphism and granulomatous lobular mastitis was observed.RESULTS There were significant differences in genotype frequency and allele frequency of C/C and C/T between the experimental group and the control group(all P<0.05).However,there was no significant difference in frequency of T/T genotype between the two groups(P>0.05).In addition,there was no significant difference in genotype frequency and allele frequency of A/A,A/C and C/C between the two groups(P>0.05).CONCLUSION MTHFR gene C677T locus polymorphism is closely related to granulomatous lobular mastitis.
文摘Objective To review the association of methylene tetrahydrofolate reductase (MTHFR) C677T mutant with coronary artery disease, as well as to highlight the results of some of these studies and to emphasize the need to focus on the genetic architecture of CAD. Data SourcesData used in this article is mainly from relevant articles obtained through Pubmed, OVID and Google Scholar published from 1980 to 2008. Major studies and trials in this period were taken into account to draw accurate conclusion on the relation of those mutations in MTHFR with homocysteinemia and CAD. ResultOur analysis shows that hyperhomocysteinemia, a risk factor for occlusive arterial diseases, can be caused by disruptions of homocysteine metabolism catalyzed by MFTHR. A common alanine to valine mutation in MTHFR may contribute to mild heperhomocysteinemia in CAD. Individuals with the homozygous mutant genotype had higher plasma homocysteine, particularly when plasma folate was below the median value. ConclusionThis MTHFR mutant in the setting of insufficient folate may be a risk factor of CAD and can be regarded as a model of genetic-environmental interaction in the development of CAD.
文摘目的分析亚甲基四氢叶酸还原酶(MTHFR)基因多态性对脑梗死患者阿替普酶静脉溶栓后出血性转化(HT)的影响。方法回顾性分析2020年7月—2023年7月在安徽医科大学附属阜阳人民医院接受治疗的120例脑梗死患者的临床资料。依据治疗后24~72 h HT发生情况分为HT组(15例)、无HT组(105例)。比较两组基线资料、MTHFR基因多态性、纤维蛋白原(Fib)、同型半胱氨酸(Hcy)。采用多因素一般Logistic回归模型分析脑梗死患者阿替普酶静脉溶栓后HT发生的危险因素。绘制受试者工作特征(ROC)曲线,分析入院时美国国立卫生院卒中量表(NIHSS)评分、Hcy预测脑梗死患者阿替普酶静脉溶栓后HT发生的价值。结果HT组心房颤动发生率、MTHFR基因型677CT占比、入院时NIHSS评分、Hcy水平均高于无HT组(P<0.05)。多因素一般Logistic回归分析结果显示:心房颤动史[OR=1.478(95%CI:1.126,1.940)]、入院时NIHSS评分升高[OR=1.656(95%CI:1.125,2.438)]、MTHFR基因型为677CT[OR=1.871/2.362(95%CI:1.052,3.328/1.081,4.652)]、Hcy水平升高[OR=2.149(95%CI:1.108,4.168)]均为脑梗死患者阿替普酶静脉溶栓后HT发生的危险因素(P<0.05)。ROC曲线分析结果显示,入院时NIHSS评分、Hcy均可预测脑梗死患者阿替普酶静脉溶栓后HT发生,其敏感性分别为80.0%(95%CI:0.765,0.883)、73.3%(95%CI:0.717,0.834),特异性分别为74.3%(95%CI:0.659,0.817)、74.3%(95%CI:0.824,0.931)。677CT型患者Hcy水平高于677CC、677TT型患者(P<0.05)。结论心房颤动、MTHFR基因型、入院时NIHSS评分、Hcy均为影响脑梗死患者阿替普酶静脉溶栓后HT发生的重要因素,临床应结合以上指标对高危患者进行重点筛查,尽早采取干预措施。
文摘目的探讨亚甲基四氢叶酸还原酶(MTHFR)基因多态性及纤维蛋白原(Fib)、纤溶酶原激活抑制物-1(PAI-1)与脑梗死患者下肢深静脉血栓(LDVT)的相关性。方法回顾性分析2020年1月~2022年12月在张家口市第一医院接受治疗的脑梗死患者100例。依据入院14 d后超声检查结果分为LDVT组(n=27)与无LDVT组(n=73)。比较两组基线资料信息、MTHFR基因多态性以及实验室相关指标,通过ROC分析入院时美国国立卫生研究所脑卒中量表(NIHSS)评分、Fib、PAI-1预测脑梗死患者LDVT的价值。采用多因素logistic回归分析脑梗死患者LDVT的危险因素。结果100例脑梗死患者行超声检测,发现27例(27.00%)发生LDVT,其中股静脉血栓8例(29.63%),胫前静脉血栓6例(22.22%),胫后静脉血栓4例(14.81%),腘静脉血栓4例(14.81%),腓肠肌肌间静脉血栓5例(18.52%);73例(73.00%)脑梗死患者无LDVT。LDVT组房颤、MTHFR基因多态性为CT、TT人数占比以及入院时NIHSS评分、Fib、PAI-1水平高于无LDVT组,差异有统计学意义(P<0.05);经ROC分析证实入院时NIHSS评分、Fib、PAI-1均可预测脑梗死患者LDVT,曲线下面积分别为0.795、0.763、0.801(P<0.05);多因素logistic回归分析证实,房颤、入院时NIHSS评分≥14.810分、MTHFR基因多态性为CC和CT、Fib≥3.800 g L以及PAI-1≥41.005 ng L是脑梗死患者LDVT的危险因素(P<0.05)。结论MTHFR基因多态性及Fib,PAI-1与脑梗死患者LDVT的发生密切相关,房颤、入院时NIHSS评分≥14.810分、MTHFR基因多态性为CC和CT、Fib≥3.800 g L以及PAI-1≥41.005 ng L是脑梗死患者LDVT的危险因素,临床应对符合以上因素的患者进行重点筛查,尽早采取干预措施,改善患者预后。
